URGN•benzinga•
Ladenburg Thalmann Assumes UroGen Pharma at Buy, Announces Price Target of $31
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 19, 2025 by benzinga